SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-007690
Filing Date
2021-01-26
Accepted
2021-01-26 16:54:21
Documents
16
Period of Report
2021-01-20
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm214247d1_8k.htm   iXBRL 8-K 27235
2 EXHIBIT 16.1 tm214247d1_ex16-1.htm EX-16.1 2731
6 GRAPHIC tm214247d1_ex16-1img001.jpg GRAPHIC 8155
7 GRAPHIC tm214247d1_ex16-1img002.jpg GRAPHIC 4373
8 GRAPHIC tm214247d1_ex16-1img003.jpg GRAPHIC 17169
  Complete submission text file 0001104659-21-007690.txt   244728

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nwbo-20210120.xsd EX-101.SCH 3178
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nwbo-20210120_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nwbo-20210120_pre.xml EX-101.PRE 22705
9 EXTRACTED XBRL INSTANCE DOCUMENT tm214247d1_8k_htm.xml XML 3514
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35737 | Film No.: 21554791
SIC: 2834 Pharmaceutical Preparations